De Pasquale Concetta, Pistorio Maria Luisa, Veroux Massimiliano, Barbagallo Noemi, Cottone Provvidenza Marisa, Ekser Burcin, Lorenzano Giuseppina, Giaquinta Alessia, Veroux Pierfrancesco
Vascular Surgery and Organ Transplant Unit, Department of Educational Sciences, University of Catania, Catania, Italy.
Vascular Surgery and Organ Transplant Unit, Department of General Surgery and Medical-Surgical Specialties, University Hospital of Catania, Catania, Italy.
Front Psychiatry. 2024 May 1;15:1338934. doi: 10.3389/fpsyt.2024.1338934. eCollection 2024.
Few studies have evaluated the psychological distress of COVID-19 in kidney transplantation and the psychological impact that the COVID-19 pandemic has had on kidney transplant recipients is not yet well understood. The present study aimed to investigate the change in symptom burden and health-related quality of life in the two years after initial assessment, by outlining the change over time of symptoms at 12 and 24 months of follow-up.
This is a follow-up study. We performed a study published in 2021 (phase 1 of COVID-19); of the 89 kidney transplant recipients evaluated in this study, 60 completed the 12 months follow-up (March 2021 June 2021, phase 2 of COVID-19) and 57 completed the 24 months follow-up (March 2022 June 2022, post COVID-19). The same tools as in previous study were administered: the questionnaire on emotional state and psychophysical well-being during COVID-19, the Middlesex Hospital Questionnaire (MHQ) to provide a simple and rapid quantification of the psychological and somatic symptoms and the Short Form Health Survey 36 (SF-36) was used to assess health-related quality of life.
Compared to the first and second phase of COVID-19, the mean score of quality of life variables were higher in the post COVID-19 phase; thus the recipients physical health, mental health and their perception of their general health improved. Regarding the psychopathology variables the levels of Anxiety, Depression and Phobia in the Post COVID-19 phase decreased, while the Somatization score was higher. Lastly, burden of COVID-19 scores in the third phase, significantly decreased.
Our study highlights a significant association between mental health and the burden of COVID-19 pandemic in kidney transplant recipients. This study showed, a significant worsening, over time, of some specific symptoms, such as somatization and phobias. However, the results showed that depressive symptoms improved during the study period. Long-term monitoring of kidney transplant recipients therefore remains fundamental. These results confirmed the need to provide integrated multidisciplinary services to adequately address the long-term effects of the COVID-19 pandemic on the mental health of the most vulnerable subjects.
很少有研究评估肾移植受者感染新冠病毒后的心理困扰,且新冠疫情对肾移植受者的心理影响尚未得到充分了解。本研究旨在通过概述随访12个月和24个月时症状随时间的变化,调查初次评估后两年内症状负担和健康相关生活质量的变化。
这是一项随访研究。我们对2021年发表的一项研究(新冠疫情第1阶段)进行了跟进;在该研究评估的89名肾移植受者中,60人完成了12个月的随访(2021年3月至2021年6月,新冠疫情第2阶段),57人完成了24个月的随访(2022年3月至2022年6月,新冠疫情后阶段)。使用了与之前研究相同的工具:新冠疫情期间情绪状态和身心健康问卷、米德尔塞克斯医院问卷(MHQ)以简单快速地量化心理和躯体症状,以及简短健康调查36项量表(SF - 36)来评估健康相关生活质量。
与新冠疫情第1阶段和第2阶段相比,新冠疫情后阶段生活质量变量的平均得分更高;因此,受者的身体健康、心理健康及其对总体健康的认知有所改善。关于精神病理学变量,新冠疫情后阶段的焦虑、抑郁和恐惧水平有所下降,而躯体化得分更高。最后,第三阶段的新冠负担得分显著下降。
我们的研究强调了肾移植受者心理健康与新冠疫情负担之间的显著关联。这项研究表明,随着时间的推移,一些特定症状,如躯体化和恐惧症,有显著恶化。然而,结果显示在研究期间抑郁症状有所改善。因此,对肾移植受者进行长期监测仍然至关重要。这些结果证实了需要提供综合多学科服务,以充分应对新冠疫情对最脆弱人群心理健康的长期影响。